DIRECT INVOLVEMENT OF CD7 (GP40) IN ACTIVATION OF TCR-GAMMA/DELTA + T-CELLS

被引:39
作者
CARREL, S
SALVI, S
RAFTI, F
FAVROT, M
RAPIN, C
SEKALY, RP
机构
[1] UNIV MONTREAL, CLIN RES INST MONTREAL, MONTREAL H3C 3J7, QUEBEC, CANADA
[2] CTR LEON BERARD, F-69373 Lyon, FRANCE
关键词
D O I
10.1002/eji.1830210515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study we reported that on T cell receptor (TcR) gamma/delta+ cells from three cell lines Peer, MOLT-13 and ICRF-1, the T cell antigen CD7 (gp40) can be directly involved in the activation process. This is shown by a rapid increase in cytoplasmic free calcium after stimulation of these cells with an anti-CD7 monoclonal antibody (mAb). Activation through CD7 was further confirmed by measuring the production of interleukin 2 in ICRF-1 cells stimulated with anti-CD7 mAb. In addition induction of mRNA for tumor necrosis factor (TNF)-alpha and TNF-beta in Peer and for granulocyte-macrophage-colony-stimulating factor in MOLT-13 was observed in these anti-CD7-stimulated cells. The same anti-CD7 antibody was unable to activate TcR-alpha/beta+ Jurkat cells or normal resting peripheral blood T lymphocytes. We further showed that normal resting TcR-gamma/delta+ cells were likewise activated via the CD7 molecule. TcR-gamma/delta+ cells obtained from a patient with acute lymphoblastic leukemia 3 months after autologous bone marrow transplantation were induced to proliferate, as measured by [H-3]thymidine incorporation after stimulation with anti-CD7 mAb but not with anti-CD3 mAb. Interestingly TcR-alpha/beta+ cells from the same donor tested in parallel were not stimulated by anti-CD7 but by anti-CD3 mAb. In essence these findings contribute to the idea that on TcR-gamma/delta+ cell, the CD7 antigen could play an important role during T cell differentiation.
引用
收藏
页码:1195 / 1200
页数:6
相关论文
共 53 条
[51]   CHROMATIN CONFIGURATION OF THE HUMAN CD2 GENE LOCUS DURING T-CELL DEVELOPMENT [J].
WOTTON, D ;
FLANAGAN, BF ;
OWEN, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (11) :4195-4199
[52]  
WU YJ, 1988, J IMMUNOL, V141, P1476
[53]  
WU YJ, 1987, BLOOD S, V70, P106